HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Graham W Slack Selected Research

Therapeutics

6/2023Diagnostic, Prognostic, and Predictive Role of Next-Generation Sequencing in Mature Lymphoid Neoplasms.
10/2022Clinicopathological characteristics and long-term outcomes of plasmablastic lymphoma in British Columbia.
1/2021Characterization of DLBCL with a PMBL gene expression signature.
1/2020Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing.
1/2019Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma.
12/2018Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD.
8/2017A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
3/2013Next-generation sequencing discoveries in lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Graham W Slack Research Topics

Disease

16Neoplasms (Cancer)
10/2021 - 09/2012
15Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2024 - 10/2012
7Lymphoma (Lymphomas)
06/2023 - 03/2013
6Hodgkin Disease (Hodgkin's Disease)
11/2022 - 03/2014
4Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2021 - 03/2014
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2021 - 03/2014
2Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2022 - 01/2020
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2020 - 05/2017
2Immunoglobulin G4-Related Disease
01/2018 - 04/2017
1Plasmablastic Lymphoma
10/2022
1T-Cell Lymphoma (Lymphoma, T Cell)
11/2021
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2021
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2021
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2020
1Lymphangioma (Cavernous Lymphangioma)
06/2018
1Chylous Ascites
06/2018
1Cystic Lymphangioma (Hygroma)
06/2018
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
01/2018
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2018
1Rheumatic Diseases (Rheumatism)
01/2018
1Leukopenia
08/2017
1Anemia
08/2017
1Thrombocytopenia (Thrombopenia)
08/2017
1Neutropenia
08/2017
1Leukemia
05/2017
1Hypereosinophilic Syndrome (Loeffler Endocarditis)
04/2017
1Eosinophilia
04/2017
1Rare Diseases (Rare Disease)
04/2017
1Lymphadenopathy
04/2017
1Disease Progression
06/2015
1Hepatitis C
05/2015

Drug/Important Bio-Agent (IBA)

18Rituximab (Mabthera)FDA Link
10/2021 - 10/2012
9Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 09/2012
7Vincristine (Oncovin)FDA LinkGeneric
01/2017 - 10/2012
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2017 - 10/2012
6Prednisone (Sone)FDA LinkGeneric
01/2017 - 10/2012
5Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2013
3Biomarkers (Surrogate Marker)IBA
06/2023 - 05/2017
3Formaldehyde (Formol)FDA Link
10/2021 - 09/2015
3ParaffinIBA
10/2021 - 09/2015
3Vinblastine (Vinblastine Sulfate)FDA Link
01/2021 - 09/2012
3Bleomycin (Blenoxane)FDA LinkGeneric
01/2021 - 09/2012
3Dacarbazine (DIC)FDA LinkGeneric
01/2021 - 09/2012
2Immunoglobulins (Immunoglobulin)IBA
10/2018 - 04/2017
2SteroidsIBA
06/2018 - 04/2017
2Immunoglobulin G (IgG)IBA
01/2018 - 04/2017
2Etoposide (VP 16)FDA LinkGeneric
08/2017 - 06/2015
2GemcitabineFDA Link
08/2017 - 01/2017
1TNF Receptor-Associated Factor 3IBA
04/2024
1SphingolipidsIBA
11/2021
1MicroRNAs (MicroRNA)IBA
11/2021
1Messenger RNA (mRNA)IBA
11/2021
1obinutuzumabIBA
10/2021
1Monoclonal AntibodiesIBA
10/2021
1Immune Checkpoint InhibitorsIBA
10/2021
1RNA (Ribonucleic Acid)IBA
01/2020
1Protein Isoforms (Isoforms)IBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1AntigensIBA
01/2020
1ChromatinIBA
01/2019
1Bendamustine HydrochlorideFDA Link
01/2019
1hemoglobin Brisbane (HbGL)IBA
01/2018
1Oxaliplatin (Eloxatin)FDA LinkGeneric
08/2017
1Lenalidomide (CC 5013)FDA Link
08/2017
1Immunoglobulin E (IgE)IBA
04/2017
1Guanosine Diphosphate (GDP)IBA
01/2017
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2017
1Cisplatin (Platino)FDA LinkGeneric
01/2017
1R-CHOP protocolIBA
10/2016
1Indicators and Reagents (Reagents)IBA
09/2015
1carboxyl radical (COO-)IBA
09/2015
1IfosfamideFDA LinkGeneric
06/2015
1Cytarabine (Cytosar-U)FDA LinkGeneric
06/2015
1Methotrexate (Mexate)FDA LinkGeneric
06/2015
1Antiviral Agents (Antivirals)IBA
05/2015
1LigandsIBA
03/2014

Therapy/Procedure

8Therapeutics
06/2023 - 03/2013
7Drug Therapy (Chemotherapy)
11/2022 - 05/2015
2Radiotherapy
01/2021 - 01/2021
1Organ Transplantation
01/2020
1Aftercare (After-Treatment)
05/2017
1Salvage Therapy
01/2017
1Treatment Delay
01/2016
1Cell Transplantation
06/2015
1Hematopoietic Stem Cell Transplantation
06/2015
1Transplantation
06/2015
1Splenectomy
05/2015
1Complementary Therapies (Alternative Medicine)
12/2014